These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1128771)

  • 21. Results obtained with Sturgeron applied in progressive cerebral arteriosclerosis patients controlled systematically for years.
    Hunyi L
    Ther Hung; 1974; 22(1):32-4. PubMed ID: 4844929
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experiences with flunarizine in the treatment of otoneurologic symptoms].
    Materna F
    Med Welt; 1981 Jul; 32(29):1157-60. PubMed ID: 7266354
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of patients with cerebral and diffuse arteriosclerosis with hydergine].
    Avena G
    Hospital (Rio J); 1970 Sep; 78(3):901-28. PubMed ID: 4994595
    [No Abstract]   [Full Text] [Related]  

  • 24. A double-blind placebo controlled study of cinnarizine in the prophylaxis of seasickness.
    Hargreaves J
    Practitioner; 1980 May; 224(1343):547-50. PubMed ID: 6999486
    [No Abstract]   [Full Text] [Related]  

  • 25. Seasickness treatment with cinnarizine.
    Dolmierski R
    Bull Inst Marit Trop Med Gdynia; 1983; 34(3-4):215-6. PubMed ID: 6681365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent claudication: a controlled study in parallel time of the short-term and long-term effects of cinnarizine.
    Barber JH; Reuter CA; Jageneau AH; Loots W
    Pharmatherapeutica; 1980; 2(6):401-7. PubMed ID: 7433479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of the effect of Devincan and Stugeron in patients suffering from cerebrovascular diseases treated at medical departments.
    Udvarhelyi A
    Ther Hung; 1978; 26(1):29-32. PubMed ID: 663872
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
    Ambrosi V; Gabrielli F
    Minerva Med; 1983 Mar; 74(13):685-9. PubMed ID: 6220230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of the fibrinolytic activity of dimethylbiguanide in prevention of thromboembolism in patients with angiocardiopathy].
    Molino N; Belluardo C
    Rass Int Clin Ter; 1968 Jun; 48(11):687-700. PubMed ID: 5738544
    [No Abstract]   [Full Text] [Related]  

  • 30. [The clofibrate-dipyridamole combination in the prevention and therapy of arteriosclerotic vascular disease and its complications].
    Cucinotta D; Ferretti PG; Daccò L; Mazzera F
    G Clin Med; 1977; 58(11-12):475-86. PubMed ID: 608558
    [No Abstract]   [Full Text] [Related]  

  • 31. The arteriolar effects of cinnarizine and flunarizine. Multitechnical investigations in normal volunteers and in patients with occlusive disease of the extremities secondary to arteriosclerosis.
    Verhaegen H; Roels V; Adriaensen H; Brugmans J; De Cock W; Dony J; Jageneau A; Schuermans V
    Angiology; 1974 Apr; 25(4):261-78. PubMed ID: 4818724
    [No Abstract]   [Full Text] [Related]  

  • 32. [Metabolic therapy of atherosclerosis].
    Lingetti M; Policicchio D; Ciarimboli M; Di Grezia F; Lingetti E; Policicchio F
    Clin Ter; 1979 Oct; 91(2):129-53. PubMed ID: 540478
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical evaluation of cinnarizine in hyperlipaemic patients.
    Saba P; Galeone F; Salvadorini F; Guarguaglini M; Houben JL
    G Clin Med; 1974 Aug; 55(8):586-99. PubMed ID: 4377134
    [No Abstract]   [Full Text] [Related]  

  • 34. [Preventive treatment of migraine cephalgia with stugeron and several vegetotropic drugs].
    Tsirlin MIa
    Vrach Delo; 1977 Jul; (7):118-21. PubMed ID: 898847
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of polyene phospholipid on cholesterol metabolism in arteriosclerotic patients].
    Skorepa J; Mares P; Todorovicová H
    Cas Lek Cesk; 1974; 113(26):784-6. PubMed ID: 4844780
    [No Abstract]   [Full Text] [Related]  

  • 36. [Analysis of the effectiveness of stugeron in treatment of cochlear neuritis].
    Bugaenko LP; Iakunina MS
    Zh Ushn Nos Gorl Bolezn; 1978; (2):86-8. PubMed ID: 26154
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic effectiveness of stugeron in treating allergic dermatoses].
    Shadieva ShS
    Vestn Dermatol Venerol; 1979 Aug; (8):34-7. PubMed ID: 494742
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results obtained with pyridinocarbamate in the treatment of atherosclerosis in different parta of the body].
    Bronstein J; Galeano JC; Soutric JL; Steinman J; Novaro Hueyo JA
    Prensa Med Argent; 1969 Oct; 56(32):1543-9. PubMed ID: 5405011
    [No Abstract]   [Full Text] [Related]  

  • 39. Flunarizine in microdrepanocytic disease.
    Finelli C; Ricci P; Visani G
    Haematologica; 1984; 69(2):233-4. PubMed ID: 6429009
    [No Abstract]   [Full Text] [Related]  

  • 40. [Electroencephalographic and audiometric controls in presenile and senile arteriosclerotic subjects treated with an extractive sulfomucopolysaccharide complex with fibrinolytic action].
    Sfondrini E; Barberi G
    Minerva Med; 1969 Dec; 60(99 Suppl):5082-6. PubMed ID: 4188593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.